Home/Filings/4/0001209191-15-039691
4//SEC Filing

CLEVELAND BIOLABS INC 4

Accession 0001209191-15-039691

CIK 0001318641operating

Filed

May 5, 8:00 PM ET

Accepted

May 6, 9:30 PM ET

Size

5.2 KB

Accession

0001209191-15-039691

Insider Transaction Report

Form 4
Period: 2015-05-04
Miller Langdon L
President & CMO
Transactions
  • Award

    Stock Option (right to buy)

    2015-05-04+10,00010,000 total
    Exercise: $3.00From: 2016-05-04Exp: 2025-05-04Common Stock (10,000 underlying)

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001318641

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 9:30 PM ET
Size
5.2 KB